Search - tctmd.com

Displaying 21 - 40 of 126

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

Presenter: Shephal Doshi, Josep Rodés-Cabau, Steven J. Yakubov

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Presenter: Shephal Doshi, Josep Rodés-Cabau, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Presenter: Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The MITRALTECH Program: Attributes, Challenges, and Early Clinical Data

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The M3 Program: Attributes, Challenges, and Early Clinical Data

Presenter: John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The HIGHLIFE Program: Attributes, Challenges, and Clinical Data

Presenter: Nicolo Piazza

June 22, 2018

Advertisement

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

The MITRALTECH Program: Attributes, Challenges, and Early Clinical Data

The M3 Program: Attributes, Challenges, and Early Clinical Data

The HIGHLIFE Program: Attributes, Challenges, and Clinical Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content